TrialFrontiers in immunology2025

The immunogenicity and safety of an inactivated quadrivalent influenza vaccine and a 23-valent pneumococcal polysaccharide vaccine in individuals with chronic diseases.

Wanqin Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.